Nautilus Biotechnology Announces Nature Methods Publication Showing Iterative Mapping Quantified 130 Tau Proteoform Groups; Targets About 20 Proteoform Assays By Mid-2028, AKT1 Oncology Assay Entering Early Access Late 2026

Benzinga Newsdesk www.benzinga.com Positive 61.4%

Neg 0% Neu 0% Pos 61.4%

Comments

No comments yet. Be the first!